Hypofractionated radiotherapy with simultaneous integrated boost (SIB) plus temozolomide in good prognosis patients with glioblastoma: a multicenter phase II study by the Brain Study Group of the Italian Association of Radiation Oncology (AIRO).
about
Hypofractionated radiotherapy with simultaneous integrated boost (SIB) plus temozolomide in good prognosis patients with glioblastoma: a multicenter phase II study by the Brain Study Group of the Italian Association of Radiation Oncology (AIRO).
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Hypofractionated radiotherapy ...... of Radiation Oncology (AIRO).
@en
Hypofractionated radiotherapy with simultaneous integrated boost
@nl
type
label
Hypofractionated radiotherapy ...... of Radiation Oncology (AIRO).
@en
Hypofractionated radiotherapy with simultaneous integrated boost
@nl
prefLabel
Hypofractionated radiotherapy ...... of Radiation Oncology (AIRO).
@en
Hypofractionated radiotherapy with simultaneous integrated boost
@nl
P2093
P2860
P50
P1476
Hypofractionated radiotherapy ...... n of Radiation Oncology (AIRO)
@en
P2093
Alba Fiorentino
Beatrice Detti
Daniela Doino
Daniela Greto
Federico Lonardi
Fernanda Migliaccio
Giovanni Rubino
Laura Masini
Lorenzo Livi
Luigi Pirtoli
P2860
P2888
P356
10.1007/S11547-017-0806-Y
P577
2017-09-06T00:00:00Z